ENGLISH ABSTRACT
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Surgical treatment of pulmonary metastases--surgical methods, early and long-term results].

AIM: To retrospectively evaluate the postoperative results after surgery for lung metastases from extrapulmonary origin.

METHODS: A total of 45 patients were operated on for lung metastases between Jan 1996 and Dec 2006. They were 22 (48.9%) male and 23 (51.1%) female with a mean age of 51.6 years. Unilateral operation was carried out in 34 (75.6%) of the patients and another 11 (24.4%) patients were operated on for bilateral metastases. In 8 of them a one-stage operation was performed via median sternotomy (6) and bilateral successive thoracotomies (2). Two-stage strategy was applied in 3 patients. Metastasectomy via sternotomy as a surgical procedure was performed in all cases with bilateral lesions. In one case with one-stage successive thoracotomies a lobectomy and metastasectomy were used. In the group of unilateral operation the following procedures were carried out: metastasectomy in 23 (51%), lobectomy in 7 (15.6%), extended lobectomy in 2 (4.4%), sleeve lobectomy in 1 (2.2%) and polysegmental resection in 1 (2.2%). VATS was applied in 6 (13.3%) patients.

RESULTS: No 30-day postoperative mortality was faced. There were 3 (6.7%) minor postoperative complications. The mean number of resected metastases was 2.3 per patient. The primary tumor sites were as follow: colorectal carcinoma--15 (33.3%); renal carcinoma--5 (12.1%); breast carcinoma--6 (13.3%); soft tissue fibrosarcoma--6 (13.3%); osteosarcoma--4 (8.9%); melanoma--1 (2.2%); gastric carcinoma--1 (2.2%), thyreoid gland carcinoma--1 (2.2%); suprarenal carcinoma--1 (2.2%) and carcinoma of salivary gland type--1 (2.2%). Mediastinal lymph nodes dissection was carried out in all patients and in 5 (12.1%) was found a metastatic mediastinal lymph nodes involvement. Adequate control of primary site tumor was achieved in all patients. Until the end of the study 01.01.2008, 19 (42.2%) of the patients are alive. The median survival was 38 months with 95% Confidence Interval (33-43). The gender (p=0.194), metastases diameter (p=0.211), mediastinal lymphnode involvement (p=0.102), initial clinical symptoms (p=0.233) and the primary site stage (p=0.091) can not be considered as a prognostic factors. The prognosis was significantly influenced by histology (p=0.0275), but because of small number of cases in the groups result should be interpreted with caution. The disease free interval (p=0.0348) and metastases number > 3 (p=0.0456) are considered prognostic factors.

CONCLUSION: Surgery is an integral part of multimodality treatment of lung metastases with low postoperative complication rate and good long-term results. Respectability, "disease free interval" and number of metastases are considered to be the main prognostic factors.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app